Senti Biosciences, Inc.
News
Senti Bio to Participate in Upcoming Investor Conferences
Globe Newswire SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) ( Senti Bio or the Company ), a biotechnology company developing next-generation cell and...\n more…
Critical Survey: Senti Biosciences (NASDAQ:SNTI) vs. Solid Biosciences (NASDAQ:SLDB)
Ticker Report Solid Biosciences (NASDAQ:SLDB - Get Free Report) and Senti Biosciences (NASDAQ:SNTI - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast...\n more…
Senti Biosciences (NASDAQ:SNTI) Trading Up 5.2%
Ticker Report Shares of Senti Biosciences, Inc. (NASDAQ:SNTI - Get Free Report) traded up 5.2% during mid-day trading on Thursday . The stock traded as high as $2.83 and last traded at $2.71. 11,003 shares traded...\n more…
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nSenti Biosciences just reported results for the second quarter of 2024.\nThe post SNTI Stock Earnings: Senti Biosciences Reported Results...\n more…
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
Globe Newswire Dose finding ongoing in Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including AML Commencement of $8 million grant award from CIRM...\n more…
Analyzing Senti Biosciences (NASDAQ:SNTI) & Titan Pharmaceuticals (NASDAQ:TTNP)
Ticker Report Titan Pharmaceuticals (NASDAQ:TTNP - Get Free Report) and Senti Biosciences (NASDAQ:SNTI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the...\n more…